v3 Template
A

aTyr Pharma

Biotechnology/Pharmaceuticals San Diego, USA ~520 employees
Founded
--
Employees (Est.)
~520
26 leaders known
Total Funding
$50.0M
Funding Rounds
1
Last Funding
2023-02-09

About aTyr Pharma

aTyr Pharma is focused on translating tRNA synthetase biology into new therapies for fibrosis and inflammation, leveraging evolutionary intelligence to develop innovative treatments.

Products & Services

Efzofitimod:A therapeutic candidate under development, likely focused on addressing fibrosis and inflammation.
Pangu:A program or product in the research and development pipeline, specifics not detailed in the content.
Research Programs:Various research initiatives aimed at developing new therapies based on tRNA synthetase biology.

Specialties

tRNA Synthetase Biology Therapies for Fibrosis Therapies for Inflammation

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Public Offering
T: -
FT: Public Offering 		A: 50000000
MR: -
FA: approximately $50.0 million
FAN: 50000000 		D: 2023-02-09
FD: 2023-02-09 		2 investors
Public Offering Latest
2023-02-09
$50.0M
2 investors (Pro only)

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

E

Eric Benevich

Director

T

Timothy P. Coughlin

Chairman

J

Jane Gross, Ph.D.

S

Svetlana Lucas, Ph.D.

Director

S

Sara L. Zaknoen, M.D.

Director

J

Jane A. Gross

Director

View 23 more team members with Pro

Unlock Full Team Directory

Recent News

aTyr Pharma Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biotechnology/Pharmaceuticals
Company Size
~520 employees (est.)
Locations
San Diego, USA
San Diego
San Diego, CA +1 more

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro